Leading the strengthening of global health through research and collaboration in Asia
The Asia Pacific Foundation for Infectious Diseases (APFID),
Asia’s first international foundation specifically for infectious diseases, was founded to improve the health in Asia by strengthening and coordinating national and international research-related activities on infectious diseases and antimicrobial resistance in the Asia Pacific region.
“APFID aims to contribute to the improvement of public health in the Asia Pacific region through international collaboration for research on infectious diseases and antimicrobial resistance.”
APFID hopes to represent the central system that controls and supports international collaboration for research on infectious diseases and antimicrobial agents and resistance in the Asia Pacific region.
"Committed to the future of health in Asia"
APFID C.A.R.E.S the future of health in Asia since 1996
APFID serves as the core infrastructure for leading research on infectious diseases and antimicrobial resistance in the Asia Pacific region. Based on basic research, it collaborates with relevant institutions and academic societies worldwide to conduct international collaborative research, monitor antimicrobial resistance continuously, exchange of the most recent information, and carry out campaigns to prevent the spread of antimicrobial resistance.
Conference
ISAAR
International Symposium on Antimicrobial Agents and Resistance
Awareness
SuperU
SuperU (against superbug) Campaign
Resource
ABB
Asian Bacterial Bank
Experiment
IDRI
Infectious Disease Research Institute
Surveillance
ANSORP
Asian Network for Surveillance of Resistant Pathogens
“The rise of multidrug-resistant microorganisms is a significant global health threat, highlighting the need for countries to work together for effective surveillance and control. The Asia Pacific Foundation for Infectious Disease (APFID) plays a vital role in this global network, helping to develop strategies to tackle antimicrobial resistance across Asia, the Middle East, and beyond. APFID is a shining example of what can be achieved through international cooperation. The global scientific community truly appreciates the exceptional efforts and accomplishments in these important missions”.
Walter R. Wilson M.D.
Mayo Clinic, USA
Burden of AMR in Asia should be decreased or delayed in the near future from the efforts of ANSORP
“I have joined ANSORP since 2002. ANSORP is the largest collaborative network on surveillance of antimicrobial resistance (AMR) among Asian countries. ANSORP has been doing surveillance of AMR among Asian countries for many years and the collected data clearly show that AMR is prevalent in Asian countries, and they are sufficient to proceed to solving AMR problems in Asia”.
Visanu Thamlikitkul
Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand
APFID provides the platform for scientific exchange between Asian experts on infectious diseases
“APFID provides the platform for scientific exchange between Asian experts on infectious diseases. Through multiple systems, APFID improves the international collaboration of research activities on infectious diseases and antimicrobial resistance surveillance in Asia. We believe it will play a more important role in the future”.
Hui Wang
Peking University People’s Hospital, PR China
Continued monitoring of the resistance patterns in this region is essential to contain the spread of the resistance
“ANSORP was established to monitor globally the in vitro susceptibility of medically important human pathogens. The Asia Pacific region is the epicenter of the emergence and dissemination of a variety of multidrug-resistant bacteria. Surveillance studies from ANSORP have provided important information about changes in the spectrum of microbial pathogens and trends in antimicrobial resistance patterns in nosocomial and community-acquired infections in Asia. Continued monitoring of the resistance patterns in this region is essential to contain the spread of resistance as well as to guide effective antimicrobial therapy.”
Cheng-Hsun Chiu
Chang Gung Memorial Hospital, Taiwan
